De Sèze J - Search Results

1

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.

Laplaud DA, Casey R, Barbin L, Debouverie M, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Lubetzki C, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Wahab A, Labauge P, Magy L, Defer G, Guennoc AM, Maubeuge N, Labeyrie C, Patry I, Nifle C, Casez O, Michel L, Rollot F, Leray E, Vukusic S, Foucher Y; SFSEP and OFSEP groups. Laplaud DA, et al. Among authors: de seze j. Neurology. 2019 Aug 13;93(7):e635-e646. doi: 10.1212/WNL.0000000000007938. Epub 2019 Jul 12. Neurology. 2019. PMID: 31300547 Free PMC article.

2

Effect of glatiramer acetate (Copaxone) given orally in human patients: interleukin-10 production during a phase 1 trial.

de Seze J, Edan G, Labalette M, Dessaint JP, Vermersch P. de Seze J, et al. Ann Neurol. 2000 May;47(5):686. Ann Neurol. 2000. PMID: 10805349 Clinical Trial. No abstract available.

3

[Spinal cord magnetic resonance imaging in multiple sclerosis: importance of determining degree of atrophy as a marker of disease course].

De Seze J, Ayachi M, Stojkovic T, Gauvrit JY, Saint Michel T, Pruvo J, Vermersch P. De Seze J, et al. Rev Neurol (Paris). 2000 May;156(5):491-6. Rev Neurol (Paris). 2000. PMID: 10844368 French.

4

Paroxysmal kinesigenic choreoathetosis as a presenting symptom of multiple sclerosis.

de Seze J, Stojkovic T, Destée M, Destée A, Vermersch P. de Seze J, et al. J Neurol. 2000 Jun;247(6):478-80. doi: 10.1007/s004150070184. J Neurol. 2000. PMID: 10929284 Review. No abstract available.

5

Autonomic dysfunction in multiple sclerosis: cervical spinal cord atrophy correlates.

de Seze J, Stojkovic T, Gauvrit JY, Devos D, Ayachi M, Cassim F, Saint Michel T, Pruvo JP, Guieu JD, Vermersch P. de Seze J, et al. J Neurol. 2001 Apr;248(4):297-303. doi: 10.1007/s004150170204. J Neurol. 2001. PMID: 11374094

6

Acute myelopathies: Clinical, laboratory and outcome profiles in 79 cases.

de Seze J, Stojkovic T, Breteau G, Lucas C, Michon-Pasturel U, Gauvrit JY, Hachulla E, Mounier-Vehier F, Pruvo JP, Leys D, Destée A, Hatron PY, Vermersch P. de Seze J, et al. Brain. 2001 Aug;124(Pt 8):1509-21. doi: 10.1093/brain/124.8.1509. Brain. 2001. PMID: 11459743

7

The prevalence of Sjögren syndrome in patients with primary progressive multiple sclerosis.

de Seze J, Devos D, Castelnovo G, Labauge P, Dubucquoi S, Stojkovic T, Ferriby D, Vermersch P. de Seze J, et al. Neurology. 2001 Oct 23;57(8):1359-63. doi: 10.1212/wnl.57.8.1359. Neurology. 2001. PMID: 11673571

8

[Hearing loss in multiple sclerosis: clinical, electrophysiologic and radiological study].

de Seze J, Assouad R, Stojkovic T, Desaulty A, Dubus B, Vermersch P. de Seze J, et al. Rev Neurol (Paris). 2001 Nov;157(11 Pt 1):1403-9. Rev Neurol (Paris). 2001. PMID: 11924008 French.

9

[Sensory disorders in multiple sclerosis (before optic neuropathy)].

Assouad R, de Seze J, Vermersch P. Assouad R, et al. Among authors: de seze j. Rev Neurol (Paris). 2001 Dec;157(12):1579-82. Rev Neurol (Paris). 2001. PMID: 11924461 French. No abstract available.

10

[Treatment of progressive multiple sclerosis with cyclophosphamide].

Zephir H, De Seze J, Sénéchal O, Stojkovic T, Ferriby D, Deliss B, Dubus B, Verier A, Hautecoeur P, Vermersch P. Zephir H, et al. Among authors: de seze j. Rev Neurol (Paris). 2002 Jan;158(1):65-9. Rev Neurol (Paris). 2002. PMID: 11938324 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

526 results

Search Page